The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. The Fluoroproducts segment provides fluoroproducts, including refrigerants, and industrial fluoropolymer resins and derivatives under the Teflon, Viton, Krytox, and Nafion brand names. The Chemical Solutions segment offers industrial and specialty chemicals for gold production, oil and gas, water treatment, electronics, and automotive industries. It also provides sodium cyanide through its mining solutions business; and performance chemicals and intermediates, such as methylamines, glycolic acid, and Vazo free radical initiators. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:CC
CUSIPN/A
Phone302-773-1000
Debt
Debt-to-Equity Ratio3.86
Current Ratio2.09
Quick Ratio1.47
Price-To-Earnings
Trailing P/E Ratio10.48
Forward P/E Ratio6.91
P/E Growth0.46
Sales & Book Value
Annual Sales$6.18 billion
Price / Sales1.14
Cash Flow$5.3258 per share
Price / Cash7.49
Book Value$4.67 per share
Price / Book8.54
Profitability
EPS (Most Recent Fiscal Year)$3.82
Net Income$746 million
Net Margins15.11%
Return on Equity107.22%
Return on Assets13.56%
Miscellaneous
Employees7,000
Outstanding Shares176,850,000
Market Cap$7.26 billion
Chemours (NYSE:CC) Frequently Asked Questions
What is Chemours' stock symbol?
Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."
How often does Chemours pay dividends? What is the dividend yield for Chemours?
Chemours declared a quarterly dividend on Friday, August 3rd. Stockholders of record on Friday, August 17th will be given a dividend of $0.25 per share on Friday, September 14th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.51%. The ex-dividend date is Thursday, August 16th. This is an increase from Chemours's previous quarterly dividend of $0.17. View Chemours' Dividend History.
How will Chemours' stock buyback program work?
Chemours announced that its Board of Directors has approved a stock buyback plan on Monday, December 4th 2017, which permits the company to buyback $500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to buy shares of its stock through open market purchases. Shares buyback plans are generally an indication that the company's management believes its shares are undervalued.
How were Chemours' earnings last quarter?
Chemours Co (NYSE:CC) posted its earnings results on Thursday, August, 2nd. The specialty chemicals company reported $1.71 EPS for the quarter, topping the Zacks' consensus estimate of $1.53 by $0.18. The specialty chemicals company had revenue of $1.82 billion for the quarter, compared to the consensus estimate of $1.82 billion. Chemours had a net margin of 15.11% and a return on equity of 107.22%. The business's revenue was up 14.4% compared to the same quarter last year. During the same period last year, the business earned $0.87 EPS. View Chemours' Earnings History.
When is Chemours' next earnings date?
What price target have analysts set for CC?
10 brokers have issued twelve-month price objectives for Chemours' stock. Their forecasts range from $47.00 to $68.00. On average, they expect Chemours' stock price to reach $59.1111 in the next year. This suggests a possible upside of 48.2% from the stock's current price. View Analyst Price Targets for Chemours.
What is the consensus analysts' recommendation for Chemours?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 4 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemours.
Who are some of Chemours' key competitors?
Some companies that are related to Chemours include ASAHI KASEI Cor/ADR (AHKSY), Koninklijke DSM (RDSMY), FMC (FMC), Johnson Matthey (JMPLY), Huntsman (HUN), Ashland Global (ASH), KURARAY Co Ltd/ADR (KURRY), W. R. Grace & Co (GRA), Olin (OLN), Ingevity (NGVT), Univar (UNVR), Balchem (BCPC), PQ Group (PQG), GCP Applied Technologies (GCP) and Innospec (IOSP).
Who are Chemours' key executives?
Chemours' management team includes the folowing people:
- Mr. Mark P. Vergnano, Pres, CEO & Director (Age 60)
- Mr. Mark E. Newman, Sr. VP & CFO (Age 55)
- Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 54)
- Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 61)
- Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 54)
Who are Chemours' major shareholders?
Chemours' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include FMR LLC (13.53%), BlackRock Inc. (9.79%), Iridian Asset Management LLC CT (3.92%), Bank of New York Mellon Corp (1.21%), Bank of New York Mellon Corp (1.21%) and Northern Trust Corp (0.96%). Company insiders that own Chemours stock include Amy Trojanowski, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano, Paul Kirsch and Richard H Brown. View Institutional Ownership Trends for Chemours.
Which institutional investors are selling Chemours stock?
CC stock was sold by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Renaissance Technologies LLC, Los Angeles Capital Management & Equity Research Inc., Canada Pension Plan Investment Board, Capital Fund Management S.A., Bank of New York Mellon Corp, Bank of New York Mellon Corp and BlackRock Inc.. Company insiders that have sold Chemours company stock in the last year include Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano and Paul Kirsch. View Insider Buying and Selling for Chemours.
Which institutional investors are buying Chemours stock?
CC stock was acquired by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, LSV Asset Management, FMR LLC, Marshall Wace LLP, Mackay Shields LLC, Morgan Stanley, Schwab Charles Investment Management Inc. and Engineers Gate Manager LP. View Insider Buying and Selling for Chemours.
How do I buy shares of Chemours?
Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Chemours' stock price today?
One share of CC stock can currently be purchased for approximately $39.89.
How big of a company is Chemours?
Chemours has a market capitalization of $7.26 billion and generates $6.18 billion in revenue each year. The specialty chemicals company earns $746 million in net income (profit) each year or $3.82 on an earnings per share basis. Chemours employs 7,000 workers across the globe.
What is Chemours' official website?
How can I contact Chemours?
Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19899. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]
MarketBeat Community Rating for Chemours (NYSE CC)
MarketBeat's community ratings are surveys of what our community members think about Chemours and other stocks. Vote "Outperform" if you believe CC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CC will underperform the S&P 500 over the long term. You may vote once every thirty days.
